Progressive macular hypomelanosis: an overview.

PubWeight™: 0.94‹?›

🔗 View Article (PMID 17298102)

Published in Am J Clin Dermatol on January 01, 2007

Authors

Germaine N Relyveld1, Henk E Menke, Wiete Westerhof

Author Affiliations

1: The Netherlands Institute for Pigment Disorders, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Articles by these authors

Noninvasive techniques for the evaluation of skin color. J Am Acad Dermatol (2006) 1.43

Immunopolarization of CD4+ and CD8+ T cells to Type-1-like is associated with melanocyte loss in human vitiligo. Lab Invest (2003) 1.41

UVB 311 nm tolerance of vitiligo skin increases with skin photo type. Acta Derm Venereol (2005) 1.40

Increased epidermal functioning wild-type p53 expression in vitiligo. Exp Dermatol (2003) 0.99

Propionibacterium acnes and the pathogenesis of progressive macular hypomelanosis. Arch Dermatol (2004) 0.98

Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study. J Am Acad Dermatol (2006) 0.97

Difference in pathogenesis between vitiligo vulgaris and halo nevi associated with vitiligo is supported by an HLA association study. Pigment Cell Res (2004) 0.88

A reactive ortho-quinone generated by tyrosinase-catalyzed oxidation of the skin depigmenting agent monobenzone: self-coupling and thiol-conjugation reactions and possible implications for melanocyte toxicity. Chem Res Toxicol (2009) 0.86

Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res (2011) 0.83

Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation. J Pathol (2002) 0.81

Progressive macular hypomelanosis is associated with a putative Propionibacterium species. J Invest Dermatol (2009) 0.79

Effect of one session of ER:YAG laser ablation plus topical 5Fluorouracil on the outcome of short-term NB-UVB phototherapy in the treatment of non-segmental vitiligo: a left-right comparative study. Photodermatol Photoimmunol Photomed (2008) 0.79

Comment on the letter by Chung et al. about progressive macular hypomelanosis. J Eur Acad Dermatol Venereol (2008) 0.75

Safety and efficacy of combined use of 4-hydroxyanisole (mequinol) 2%/tretinoin 0.01% solution and sunscreen in solar lentigines. Cutis (2004) 0.75

The effect of H₁ and H₂ receptor antagonists on melanogenesis. Indian J Dermatol Venereol Leprol (2011) 0.75

Charles Louis Drognat Landré and Gerhard Henrik Armauer Hansen; contribution from a Dutch colony to the discovery of the leprosy bacterium. Lepr Rev (2010) 0.75